ARTICLE | Company News

Belarusian State University, Double Bond Pharmaceutical International AB deal

November 9, 2015 8:00 AM UTC

The Research Institute of Physical and Chemical Problems (RI PCP) at the university granted Double Bond exclusive, worldwide rights to develop and commercialize Temodex. The deal excludes Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan and Ukraine. ...